ReiThera Srl, the Ragon Institute of Mass General, MIT, and Harvard, and IAVI are pleased to announce a collaboration to develop a novel HIV vaccine candidate that will be composed of ReiThera’s GRAd ...

First look at ReiCell-AAV next week at Advanced Therapies London, Booth 94 With three cutting-edge platforms for gene therapy and genetic vaccine production, ReiThera remains unique among CDMOs Rome, ...

ReiThera and Exothera entered into a collaboration agreement to develop a large-scale, low cost per dose manufacturing process for the production of ReiThera’s novel vaccines. The collaboration will ...

Type: Vaccine based on a novel and proprietary replication-defective simian (gorilla) adenoviral vector called GRAd, which encodes the full-length coronavirus spike protein. The GRAd vector belongs to ...

ReiThera Srl, the Ragon Institute of Mass General, MIT, and Harvard, and IAVI are pleased to announce a collaboration to develop a novel HIV vaccine candidate that will be composed of ReiThera’s GRAd ...